Weiping Qin Selected Research

Muscular Atrophy (Muscle Atrophy)

1/2021	Electrical stimulation of hindlimb skeletal muscle has beneficial effects on sublesional bone in a rat model of spinal cord injury.
1/2016	A Soluble Activin Receptor IIB Fails to Prevent Muscle Atrophy in a Mouse Model of Spinal Cord Injury.
1/2015	Anabolic steroids activate calcineurin-NFAT signaling and thereby increase myotube size and reduce denervation atrophy.
7/2014	Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter.
12/2010	Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α.
10/2010	Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy.
3/2010	Nandrolone slows hindlimb bone loss in a rat model of bone loss due to denervation.
3/2010	REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss.
1/2009	Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiping Qin Research Topics

Disease

10	Alzheimer Disease (Alzheimer's Disease) 03/2009 - 12/2003
9	Spinal Cord Injuries (Spinal Cord Injury) 12/2023 - 03/2010
9	Muscular Atrophy (Muscle Atrophy) 01/2021 - 01/2009
4	Neoplasms (Cancer) 08/2018 - 02/2016
4	Atrophy 01/2015 - 10/2010
4	Amyloidosis 12/2008 - 12/2003
3	Amyloid Plaque 03/2009 - 04/2005
3	Dementia (Dementias) 03/2009 - 12/2005
2	Bone Resorption 12/2023 - 03/2020
2	Hypertrophy 01/2017 - 01/2015
2	Adenocarcinoma 02/2016 - 03/2015
2	Diabetes Mellitus 12/2005 - 05/2004
2	Insulin Resistance 12/2005 - 05/2004
1	Osteoporosis 10/2018
1	Hyperglycemia 01/2018
1	Inflammation (Inflammations) 01/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Paralysis (Palsy) 01/2015
1	Poisoning 06/2014
1	Sarcopenia 10/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2007
1	Cognitive Dysfunction 01/2006
1	Fibrosis (Cirrhosis) 12/2005
1	Type 2 Diabetes Mellitus (MODY) 05/2004

Drug/Important Bio-Agent (IBA)

8	Amyloid beta-PeptidesIBA 03/2009 - 12/2003
6	Anabolic Androgenic SteroidsIBA 01/2015 - 03/2010
5	Nandrolone (Nortestosterone)IBA 01/2015 - 03/2010
5	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2009 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2009
4	Amyloid (Amyloid Fibrils)IBA 03/2009 - 12/2005
4	Peptides (Polypeptides)IBA 01/2009 - 12/2003
3	PolymersIBA 11/2017 - 03/2015
3	Insulin (Novolin)FDA Link 01/2016 - 05/2004
3	GlucocorticoidsIBA 07/2014 - 03/2010
2	Messenger RNA (mRNA)IBA 01/2021 - 03/2009
2	Therapeutic UsesIBA 01/2018 - 01/2006
2	MyostatinIBA 01/2017 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 01/2016 - 01/2016
2	AndrogensIBA 01/2015 - 10/2011
2	Muscle Proteins (Muscle Protein)IBA 07/2014 - 12/2010
2	Ligases (Synthetase)IBA 12/2010 - 01/2009
2	Testosterone (Sustanon)FDA Link 12/2010 - 03/2010
2	UbiquitinIBA 12/2010 - 01/2009
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2006 - 12/2003
1	Denosumab FDA Link 12/2023
1	Anabolic AgentsIBA 12/2023
1	Bone Density Conservation AgentsIBA 12/2023
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Aligeron (AS 2)IBA 03/2020
1	Cell-Penetrating PeptidesIBA 08/2018
1	CarbonIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017
1	Free RadicalsIBA 11/2017
1	MyokinesIBA 01/2017
1	Singlet OxygenIBA 02/2016
1	Activin Receptors (Activin Receptor)IBA 01/2016
1	Activins (Activin)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Calcineurin InhibitorsIBA 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	CalcineurinIBA 01/2015
1	Testosterone CongenersIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	HydrogenIBA 06/2014
1	CalciumIBA 08/2013
1	Notch ReceptorsIBA 11/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2010
1	p38 Mitogen-Activated Protein KinasesIBA 12/2010
1	PPAR gammaIBA 03/2009
1	Complementary DNA (cDNA)IBA 03/2009
1	Biomarkers (Surrogate Marker)IBA 01/2009
1	MetalsIBA 01/2009
1	Carrier Proteins (Binding Protein)IBA 01/2009
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2008
1	CarbohydratesIBA 01/2007
1	Sirtuin 1IBA 08/2006
1	NAD (NADH)IBA 08/2006
1	SirtuinsIBA 08/2006
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2006
1	Cyclooxygenase InhibitorsIBA 01/2006
1	Connective Tissue Growth FactorIBA 12/2005
1	Insulin ReceptorIBA 05/2004
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 05/2004
1	Insulysin (Insulin-Degrading Enzyme)IBA 05/2004
1	Protein Kinases (Protein Kinase)IBA 05/2004
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2004
1	Protein Isoforms (Isoforms)IBA 12/2003

Therapy/Procedure

5	Denervation 01/2015 - 03/2010
4	Therapeutics 10/2018 - 02/2016
2	Precision Medicine 01/2018 - 11/2017
2	Lasers (Laser) 01/2018 - 01/2009
2	Semiconductors 02/2016 - 03/2015
1	Intravenous Injections 01/2021
1	Laminectomy 10/2018
1	Nanospheres 01/2018
1	Stem Cell Transplantation 01/2017
1	Photochemotherapy (Photodynamic Therapy) 02/2016
1	Diet Therapy (Therapy, Diet) 01/2007
1	Caloric Restriction 04/2005